Morgan Stanley Put 170 BYD Co. Lt.../ DE000ME9RWS0 /
31/05/2024 11:52:47 | Var.+0.050 | Denaro13:52:31 | Lettera13:52:31 | Sottostante | Prezzo di esercizio | Expiration date | Tipo di opzione |
---|---|---|---|---|---|---|---|
0.210EUR | +31.25% | 0.200 Quantità in denaro: 2,500 |
0.330 Quantità in lettera: 2,500 |
- | 170.00 HKD | 20/09/2024 | Put |
GlobeNewswire
14:05
Autonomix Medical, Inc. Reports Full Year 2024 Financial Results and Provides Corporate Update
GlobeNewswire
14:00
Haoxi Health Technology Limited Reports Unaudited Financial Results for The Six Months Ended Decembe...
GlobeNewswire
14:00
Generation Lab Introduces First Platform that Measures Aging & Treatment Efficacy to Help Extend the...
GlobeNewswire
14:00
Autolus Therapeutics presents longer-term follow-up and additional data analysis of Pivotal Phase 2 ...
GlobeNewswire
14:00
Lipella Pharmaceuticals Announces Completion of Site Initiation Visit for Phase 2a Trial of LP-310 i...
GlobeNewswire
14:00
Milestone® Pharmaceuticals to Participate in the Upcoming Jefferies Global Healthcare Conference
GlobeNewswire
14:00
Aptose Announces $4.43 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules
GlobeNewswire
14:00
PodcastOne (Nasdaq: PODC) Appoints Wall Street Veteran Jon Merriman to Its Board of Directors
GlobeNewswire
14:00
ABM Named Among Barron’s 100 Most Sustainable Companies for Second Consecutive Year
GlobeNewswire
14:00
Iterum Therapeutics Receives FDA Acceptance of Resubmission of NDA for Oral Sulopenem for the treatm...
GlobeNewswire
14:00
SOND INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Sonder Holdings Inc. Investors...